Skip to main content

Table 1 Inclusion and exclusion criteria

From: 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial

Group

Criterion

Definition

Inclusion (determined on admission to PICU)

 

Age

Birth to < 16 years of age

Location

Admitted to PICU

Time frame

New admission to PICU within the last 24 h and has received IVFT for ≤ 4 h in PICU

Decision—clinician decides that IVFT is required

IVFT—all intravenous fluids (boluses and maintenance fluids but not drug dilutions) administered in PICU

Biochemistry

Admission sodium > 130 mmol/L (measured on admission or no longer than 48 h before randomization)

Exclusion

 

Age

≥ 16 years

Time frame

Received IVFT for > 4 h in PICU

Pre-existing conditions

- Admitted for a cardiac condition

- Chronic kidney disease

Disease-specific IVFT protocols

- Traumatic brain injury or at risk of cerebral oedema

- Burns

- Post-liver transplant

- Post-renal transplant

- Diabetic ketoacidosis

- Oncology patients needing hyperhydration